Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2050

1.

Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.

Miller JT, Collins CD, Stuckey LJ, Luan FL, Englesbe MJ, Magee JC, Park JM.

Pharmacotherapy. 2009 Oct;29(10):1166-74. doi: 10.1592/phco.29.10.1166.

PMID:
19792990
[PubMed - indexed for MEDLINE]
2.

Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients.

Marfo K, Akalin E, Wang C, Lu A.

Am J Health Syst Pharm. 2011 Dec 1;68(23):2276-82. doi: 10.2146/ajhp110120.

PMID:
22095818
[PubMed - indexed for MEDLINE]
3.

Rabbit antithymocyte globulin: a postoperative risk factor for sirolimus-treated renal transplant patients?

Benavides C, Mahmoud KH, Knight R, Barcenas C, Kahan BD, Van Buren CT.

Transplant Proc. 2005 Mar;37(2):822-6.

PMID:
15848544
[PubMed - indexed for MEDLINE]
4.

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D; Thymoglobulin Induction Study Group.

N Engl J Med. 2006 Nov 9;355(19):1967-77.

PMID:
17093248
[PubMed - indexed for MEDLINE]
Free Article
5.

Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.

Sollinger H, Kaplan B, Pescovitz MD, Philosophe B, Roza A, Brayman K, Somberg K.

Transplantation. 2001 Dec 27;72(12):1915-9.

PMID:
11773888
[PubMed - indexed for MEDLINE]
6.

Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.

Flaman F, Zieroth S, Rao V, Ross H, Delgado DH.

J Heart Lung Transplant. 2006 Nov;25(11):1358-62.

PMID:
17097501
[PubMed - indexed for MEDLINE]
7.

Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes.

Trofe-Clark J, Reese PP, Patel HJ, Jakobowski D, Goral S, Doll SL, Abt PL, Bloom RD.

Transplantation. 2012 Sep 15;94(5):506-12.

PMID:
22895613
[PubMed - indexed for MEDLINE]
8.

Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal.

Martin ST, Roberts KL, Malek SK, Tullius SG, Vadivel N, De Serres S, Grafals M, Elsanjak A, Filkins BA, Chandraker A, Gabardi S.

Pharmacotherapy. 2011 Jun;31(6):566-73. doi: 10.1592/phco.31.6.566.

PMID:
21923440
[PubMed - indexed for MEDLINE]
9.

Living unrelated donors in kidney transplants: better long-term results than with non-HLA-identical living related donors?

Humar A, Durand B, Gillingham K, Payne WD, Sutherland DE, Matas AJ.

Transplantation. 2000 May 15;69(9):1942-5.

PMID:
10830235
[PubMed - indexed for MEDLINE]
10.

Lack of economic benefit with basiliximab induction in living related donor adult renal transplant recipients.

Crompton JA, Somerville T, Smith L, Corbett J, Nelson E, Holman J, Shihab FS.

Pharmacotherapy. 2003 Apr;23(4):443-50.

PMID:
12680474
[PubMed - indexed for MEDLINE]
11.

Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.

Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.

Clin Exp Nephrol. 2007 Jun;11(2):151-5. Epub 2007 Jun 28.

PMID:
17593515
[PubMed - indexed for MEDLINE]
12.

Should living-unrelated renal transplant recipients receive antibody induction? Results of a clinical experience trial.

Wiland AM, Fink JC, Weir MR, Philosophe B, Blahut S, Weir MR Jr, Copenhaver B, Bartlett ST.

Transplantation. 2004 Feb 15;77(3):422-5.

PMID:
14966418
[PubMed - indexed for MEDLINE]
13.

Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.

Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O.

Transplant Proc. 2011 Mar;43(2):458-61. doi: 10.1016/j.transproceed.2011.01.035.

PMID:
21440733
[PubMed - indexed for MEDLINE]
14.

Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.

Guttmann RD, Flemming C.

Clin Transplant. 1997 Jun;11(3):185-92.

PMID:
9193840
[PubMed - indexed for MEDLINE]
15.

Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety.

Kyllönen LE, Eklund BH, Pesonen EJ, Salmela KT.

Transplantation. 2007 Jul 15;84(1):75-82.

PMID:
17627241
[PubMed - indexed for MEDLINE]
16.

Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.

Hariharan S, Alexander JW, Schroeder TJ, First MR.

Clin Transplant. 1996 Apr;10(2):186-90.

PMID:
8664516
[PubMed - indexed for MEDLINE]
17.

Rabbit antithymocyte globulin is more beneficial in standard kidney than in extended donor recipients.

Hardinger KL, Brennan DC, Schnitzler MA.

Transplantation. 2009 May 15;87(9):1372-6. doi: 10.1097/TP.0b013e3181a2475f.

PMID:
19424038
[PubMed - indexed for MEDLINE]
18.

Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.

Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.

Nephrology (Carlton). 2008 Feb;13(1):80-6. doi: 10.1111/j.1440-1797.2007.00866.x.

PMID:
18199109
[PubMed - indexed for MEDLINE]
19.

20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.

Cantarovich M, Durrbach A, Hiesse C, Ladouceur M, Benoit G, Charpentier B.

Transplantation. 2008 Dec 27;86(12):1732-7. doi: 10.1097/TP.0b013e318190659d.

PMID:
19104413
[PubMed - indexed for MEDLINE]
20.

Basiliximab as an alternative to antithymocyte globulin for early immunosuppression in lung transplantation.

Clinckart F, Bulpa P, Jamart J, Eucher P, Delaunois L, Evrard P.

Transplant Proc. 2009 Mar;41(2):607-9. doi: 10.1016/j.transproceed.2008.12.028.

PMID:
19328937
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk